MedTrace Logo

Motor Imagery for Prosthetic Gait Training in Transtibial Amputees

NCT07652619 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2026-06-17

No results posted yet for this study

Summary

This study included the development of motor imagery (i.e., the cognitive process of mentally reheasing a motor task) protocol for improving prosthetic gait among acute transtibial amputees. Further, the researchers investigated whether praciticng motor imagery before or alongside initial temporary prosthetic training (aka VESSA) would affect measures of functional status, pain, prosthethis embodiement and motor imagery ability.

Conditions

  • Transtibial Amputation - Unilateral
  • Transtibial Amputation
  • Transtibial Amputee

Interventions

BEHAVIORAL

Motor Imagery

The motor imagery intervention aimed to: (1) introduce rationale, mechanisms of action, and advantages of MI; (2) facilitate kinesthetic and functional familiarization with the prosthesis; and (3) enhance prosthetic gait, weight-bearing, balance and turning. The protocol followed MI paradigms and methodologies (e.g., combining visual and kinesthetic modalities), including the PETTLEP model that was previously used in amputees. The MI contents addressed movement range of motion, quality, timing, and lower extremity and whole-body intersegmental coordination with motor tasks serving as outcome measures not being explicitly practiced. The following components were included: 1. Introduction to MI- definition, mechanisms of effect, advantages, modalities, and perspectives. 2. Acquaintance with and embodiment of the stump, MI of the prosthesis and MI of the stump-prosthesis interaction (e.g., contact area, pressure). 3. Weight bearing and shifting during sit-to-stand, standing and gait.

Sponsors & Collaborators

  • Loewenstein Hospital

    collaborator OTHER

  • Ariel University

    lead OTHER

Principal Investigators

  • Amir Haim, MD · Loewenstein Rehabilitation Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-10
Primary Completion
2023-10-20
Completion
2023-10-20

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07652619 on ClinicalTrials.gov